BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10787465)

  • 1. Therapeutic potential of platelet-activating factor antagonism in the management of myocardial infarction.
    Loucks EB; Qayumi AK; Godin DV; English JC; Lim SP; Al Mahmeed T; Gul S
    Can J Cardiol; 2000 Apr; 16(4):497-504. PubMed ID: 10787465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB; Godin DV; Walley KR; McManus BM; Rahimian R; Granville DJ; Hong JM; Aktary FM; Qayumi AK
    Can J Cardiol; 2003 Mar; 19(3):267-74. PubMed ID: 12677282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended lung preservation with platelet-activating factor-antagonist TCV-309 in combination with prostaglandin E1.
    Qayumi AK; English JE; Duncan S; Ansley DM; Pearson B; Nikbakht-Sangari M; Sammartino C; Fradet G
    J Heart Lung Transplant; 1997 Sep; 16(9):946-55. PubMed ID: 9322146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury.
    Qayumi AK; English JC; Godin DV; Ansley DM; Loucks EB; Lee JU; Kim CW
    Ann Thorac Surg; 1998 Jun; 65(6):1690-7. PubMed ID: 9647083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):679-83. PubMed ID: 15932731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of selectin function attenuates microvascular platelet deposition and platelet-mediated myocardial injury after transient ischemia.
    Barrabés JA; Garcia-Dorado D; Mirabet M; Inserte J; Agulló L; Soriano B; Massaguer A; Padilla F; Lidón RM; Soler-Soler J
    J Am Coll Cardiol; 2005 Jan; 45(2):293-9. PubMed ID: 15653030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest.
    Khan TA; Bianchi C; Voisine P; Feng J; Baker J; Hart M; Takahashi M; Stahl G; Sellke FW
    J Thorac Cardiovasc Surg; 2004 Oct; 128(4):602-8. PubMed ID: 15457162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of infarct size in a rat model of regional myocardial ischemia and reperfusion by the synthetic peptide DAHK.
    Bar-Or D; McDonald MC; Thiemermann C
    Crit Care Med; 2006 Jul; 34(7):1955-9. PubMed ID: 16691133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological profile of TCV-309--a potent PAF antagonist.
    Terashita Z; Takatani M; Nishikawa K
    J Lipid Mediat; 1992; 5(2):183-5. PubMed ID: 1445598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart.
    Schwarz ER; Tussing T; Skobel E; Klosterhalfen B; Domanski D; Fuess JE
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):215-21. PubMed ID: 19605571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of platelet-activating-factor antagonist TCV-309 on arrhythmias and functional recovery during myocardial reperfusion.
    Tamura K; Kimura Y; Tamura T; Kitashiro S; Izuoka T; Tsuji H; Iwasaka T; Inada M
    Coron Artery Dis; 1994 Mar; 5(3):267-73. PubMed ID: 8199742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative effects of rofecoxib treatment on cardiac function after ischemia-reperfusion injury in APOE3Leiden mice are prevented by combined treatment with thromboxane prostanoid-receptor antagonist S18886 (terutroban).
    van der Hoorn JW; Jukema JW; Bekkers ME; Princen HM; Corda S; Emeis JJ; Steendijk P
    Crit Care Med; 2008 Sep; 36(9):2576-82. PubMed ID: 18679128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolically controlled reperfusion in acute myocardial infarction: should the polarizing solution be given subselectively?
    Angelini P; Haas PC; Bucciarelli Ducci C; Adams S; Ober J; Bigley J; Clubb FJ; Frazier OH
    J Invasive Cardiol; 2003 Sep; 15(9):491-6. PubMed ID: 12947208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial ischemia in intestinal postischemic shock: the effect of hypoxemic reperfusion.
    Douzinas EE; Pitaridis MT; Patsouris E; Kollias S; Boursinos V; Karmpaliotis DI; Gratsias Y; Evangelou E; Papalois A; Konstantinidou AE; Roussos C
    Crit Care Med; 2003 Aug; 31(8):2183-9. PubMed ID: 12973178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor.
    Iwase M; Yokota M; Kitaichi K; Wang L; Takagi K; Nagasaka T; Izawa H; Hasegawa T
    Crit Care Med; 2001 Mar; 29(3):609-17. PubMed ID: 11373429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of platelet activating factor in ischaemia-reperfusion injury of isolated rabbit hearts: protective effect of a specific platelet activating factor antagonist, TCV-309.
    Katoh S; Toyama J; Kodama I; Koike A; Abe T
    Cardiovasc Res; 1993 Aug; 27(8):1430-4. PubMed ID: 8221795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of bradykinin-inactivating enzymes decrease myocardial ischemia/reperfusion injury following 3 and 7 days of reperfusion.
    Schriefer JA; Broudy EP; Hassen AH
    J Pharmacol Exp Ther; 2001 Sep; 298(3):970-5. PubMed ID: 11504792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.